Keep up to date with what is happening in the world of anticoagulation and support ACE
Buy individual copies of InReview online
NEWS & EVENTS
The National Institute for Health and Care Excellence (NICE) has recommended Edoxaban (Lixiana) as an option for the treatment and secondary prevention of deep vein thrombosis and pulmonary embolism and for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation
A blood clot, also called a thromboembolism, is a serious side effect of cancer and cancer treatment. A venous thromboembolism (VTE) is a blood clot that develops in a blood vessel called a vein that carries blood to the heart. It may develop in any vein but happens most often in the legs, thighs, or pelvis. This is called deep vein thrombosis (DVT). A pulmonary embolism (PE) is a blood clot that has traveled to the lung from another place in the body. A PE can be life-threatening. Blood clots are common in patients with cancer. Many patients are not aware of the risks, symptoms, and signs of a blood clot. Go to the Cancer and Blood Clots section of the website to find out more, watch a patient experience video, learn signs and symptoms of a blood clot and how you can help prevent one if you have cancer and download a patient alert card.
This quality standard covers identification, treatment and management of atrial fibrillation (including paroxysmal, persistent and permanent atrial fibrillation, and atrial flutter) in adults (18 years and older). It includes a Quality Statement on Self-managment with coagulometers for people with AF and also a Quality Statement on not using aspirin as a sole therapy for stroke prevention in AF.
Access to the new anticoagulants: A joint statement from Anticoagulation Europe & Lifeblood: The Thrombosis Charity
Access to the new anticoagulants: A joint statement from Anticoagulation Europe & Lifeblood: The Thrombosis Charity Lifeblood and Anticoagulation Europe are both very concerned that the NICE recommendations that there should be equal access to VKAs (warfarin) and NOACs in the NICE approved indications are not being implemented. The NHS constitution states that patients should not be denied access to NICE approved drugs.
ACE’s new report shows there is a worrying trend that healthcare commissioners are not aware of how many people in their locality have one of the early warning signs of being at an increased risk of a stroke, atrial fibrillation (AF). With less than half of clinical commissioning groups (CCGs) having assessed the prevalence of the condition in their area, and almost two thirds not having assessed the cost of their anticoagulation service.
Peter has been self-monitoring for some years and in this video explains why he made that decision and the benefits he obtains from self-monitoring
Welcome to Anticoagulation Europe
Patient Experience Videos
By the end of 2016, there will be more than 1,000 people diagnosed with cancer every day in the UK. One of the side effects of cancer and its treatment can be blood clots. Blood clots pose a very significant risk to cancer patients. Up to 20% of cancer patients will experience a blood clot.
Many patients are not made aware of there risk of developing a blood clot when they have cancer.
Teresa’s video shares her experience of having cancer and deep vein thrombosis.
Are you taking warfarin? Are you thinking about self-monitoring your INR? Roy’s video shares his experience of the benefits of self-monitoring
We rely on donations and subscriptions so please consider joining or making a donation to enable us to coninue our work.
You can donate by clicking on to the link to right of this page. For easy ways to help us raise funds, at no cost to you, click on Give as You Live at the bottom of the page.
AntiCoagulation Europe are raising free donations through easyfundraising.
If you’re shopping online then you could help, and it won’t cost you a penny!
Here’s how easy it is to do:
Just visit a retailer or Amazon via the easyfundraising website and any purchases you make will raise a free donation for us. It’s that simple!
They work with the leading retailers including Amazon, John Lewis, Argos and Marks and Spencer to name but a few.
It takes just a couple of minutes to register for free and no payment details are needed.
Please visit their page to find out more: